Healthcare Infection Control Practices Advisory Committee, (HICPAC), 61427 [E8-24563]
Download as PDF
<![CDATA[
61427
Federal Register / Vol. 73, No. 201 / Thursday, October 16, 2008 / Notices
requirement in its information
collection request, but had not included
the recordkeeping requirement of the
medical log. In addition, CDC is
changing the requirement from
reporting gastrointestinal illness to
reporting all diseases of public health
significance. This submission includes
the medical log recordkeeping
requirement, for an additional 2,375
burden hours.
Respondents include airline pilots,
ships’ captains, importers, medical
professionals, and travelers. The nature
of the quarantine response dictates
which forms are completed by whom.
There are no costs to respondents
except their time to complete the forms.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Citation
Responses per
respondent
Average burden
per respondent
(in hours)
Total burden
(in hours)
71.21 Radio report death/illness ...................................................
71.21(c) Medical log ......................................................................
71.3 Designation of yellow fever vaccination centers ...................
71.33(c) Report by person(s) in isolation or surveillance .............
71.35 Report of death/illness in port .............................................
Outbreak of public health significance ............................................
Reporting of ill passenger(s) ...........................................................
71.51(b)(3) Admission of cats/dogs; death/illness ........................
71.51(d) Dogs/cats; certification of confinement, vaccination .......
71.52(d) Turtle importation permits ...............................................
71.53(d) Importer registration—nonhuman primates ....................
71.53(d) Recordkeeping ................................................................
71.55 Permit for dead body ..........................................................
71.56(a)(ii) Request for exemption ...............................................
71.56(a)(iii) Appeal ........................................................................
71.56(c) Appeal .............................................................................
9,500
9,500
500
11
5
2,700,000
800
5
1,200
10
40
30
5
12
5
5
1
1
1
1
1
1
1
1
1
1
1
4
1
1
1
1
2/60
15/60
1
3/60
30/60
5/60
5/60
3/60
15/60
30/60
10/60
30/60
1
1
1
1
317
2,375
500
1
3
225,000
67
1
300
5
67
60
5
12
5
5
Total ..........................................................................................
............................
............................
............................
228,723
Dated: October 1, 2008.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–24568 Filed 10–15–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee, (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates:
9 a.m.–5 p.m., November 13, 2008.
9 a.m.–1 p.m., November 14, 2008.
Place: The Washington Marriott, 1221
22nd Street, NW., Washington, DC 20037.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Preparedness, Detection, and
Control of Infectious Diseases (NCPDCID),
regarding (1) The practice of hospital
infection control; (2) Strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) Periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will
include a follow-up discussion of Health and
Human Services Healthcare-Associated
Infections Elimination Process, Urinary Tract
Infections Guideline, and Norovirus
Guideline.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Wendy Vance, HICPAC, Division of
Healthcare Quality Promotion, NCPDCID,
CDC, l600 Clifton Road, NE., Mailstop D–10,
Atlanta, Georgia 30333 Telephone (404) 639–
2891.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: October 7, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E8–24563 Filed 10–15–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control/ Initial Review Group,
(NCIPC/IRG)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned review group:
Times and Dates:
7 p.m.–8 p.m., November 18, 2008 (Open).
7:45 a.m.–5 p.m., November 19, 2008
(Closed).
7:45 a.m.–5 p.m., November 20, 2008
(Closed).
7:45 a.m.–5 p.m., November 21, 2008
(Closed).
Place: The W Hotel, 3377 Peachtree Road,
NE., Atlanta, Georgia 30326, Telephone:
(678) 500–3181.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
]]>Agencies
[Federal Register Volume 73, Number 201 (Thursday, October 16, 2008)]
[Notices]
[Page 61427]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-24563]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee,
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
committee:
Times and Dates:
9 a.m.-5 p.m., November 13, 2008.
9 a.m.-1 p.m., November 14, 2008.
Place: The Washington Marriott, 1221 22nd Street, NW.,
Washington, DC 20037.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, and the Director, National Center for Preparedness,
Detection, and Control of Infectious Diseases (NCPDCID), regarding
(1) The practice of hospital infection control; (2) Strategies for
surveillance, prevention, and control of infections (e.g.,
nosocomial infections), antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) Periodic updating
of guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Discussed: The agenda will include a follow-up
discussion of Health and Human Services Healthcare-Associated
Infections Elimination Process, Urinary Tract Infections Guideline,
and Norovirus Guideline.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Wendy Vance, HICPAC,
Division of Healthcare Quality Promotion, NCPDCID, CDC, l600 Clifton
Road, NE., Mailstop D-10, Atlanta, Georgia 30333 Telephone (404)
639-2891.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: October 7, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. E8-24563 Filed 10-15-08; 8:45 am]
BILLING CODE 4163-18-P
